Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

• Published in: Japanese journal of ophthalmology Vol. 66; no. 4; pp. 379 - 385
• Main Authors: Tanaka, Koji, Koizumi, Hideki, Tamashiro, Tamaki, Itagaki, Kanako, Nakayama, Makiko, Maruko, Ichiro, Wakugawa, Sorako, Terao, Nobuhiro, Onoe, Hajime, Wakatsuki, Yu, Kasai, Akihito, Ogasawara, Masashi, Shintake, Hiroaki, Sugano, Yukinori, Yamamoto, Akiko, Kataoka, Keiko, Hasegawa, Taiji, Izumi, Takahiko, Kawai, Moeko, Maruko, Ruka, Sekiryu, Tetsuju, Okada, Annabelle A., Iida, Tomohiro, Mori, Ryusaburo
• Format: Journal Article
• Language: English
• Published: Tokyo Springer Japan 01.07.2022; Springer Nature B.V
• Subjects: Acuity; Age; Age related diseases; Clinical Investigation; Complications; Eye; Eye diseases; Iritis; Lesions; Macular degeneration; Medicine; Medicine & Public Health; Monoclonal antibodies; Ophthalmology; Patients; Retina; Vascular diseases; Vascularization; Visual acuity; Polypoidal choroidal vasculopathy; Treatment; Age-related macular degeneration; Brolucizumab; Multicenter study

Purpose To investigate short-term treatment outcomes of intravitreal brolucizumab (IVBr) for treatment-naïve neovascular age-related macular degeneration (AMD) in a Japanese multicenter study. Study design Retrospective case control study Methods The subjects were 58 eyes of 57 patients with neovasc...